DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Betamethasone acetate; betamethasone sodium phosphateis the generic ingredient in two branded drugs marketed by Am Regent and Merck Sharp Dohme, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.
There are sixty-six drug master file entries for betamethasone acetate; betamethasone sodium phosphate. Seven suppliers are listed for this compound.
Recent Clinical Trials for betamethasone acetate; betamethasone sodium phosphate
Identify potential brand extensions & 505(b)(2) entrants
|University of Kentucky||Early Phase 1|
Pharmacology for betamethasone acetate; betamethasone sodium phosphate
|Drug Class||Corticosteroid |
|Mechanism of Action||Corticosteroid Hormone Receptor Agonists |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Merck Sharp Dohme||CELESTONE SOLUSPAN||betamethasone acetate; betamethasone sodium phosphate||INJECTABLE;INJECTION||014602-001||Approved Prior to Jan 1, 1982||AB||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|Am Regent||BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE||betamethasone acetate; betamethasone sodium phosphate||INJECTABLE;INJECTION||090747-001||Jul 31, 2009||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|Merck Sharp Dohme||CELESTONE SOLUSPAN||betamethasone acetate; betamethasone sodium phosphate||INJECTABLE;INJECTION||014602-001||Approved Prior to Jan 1, 1982||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>Patent No.||>Patent Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.